Rarecells Diagnostics
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
180 Varick St, New York City, New York, ...Phone Number
(512) 507-8777Website
www.rarecells.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Rarecells Diagnostics
Rarecells, Inc. is a healthcare company focused on the development and commercialization of non-invasive Early Cancer Detection tests. These tests are based on the ISET® platform technology that is able to extract from blood cancer cells from any type of cancer. Cancer cells extracted by ISET® are then diagnostically identified through immune-morpho-molecular analyses combined with image analyses and AI. This approach is believed to be a significant advancement in the highly sensitive non-invasive detection of cancer's signals providing a powerful tool for early cancer detection through the identification of the first circulating cancer cells.Explore more
Rarecells Diagnostics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Rarecells Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Rarecells Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Rarecells Diagnostics recently announced quarterly report
Click to see if Rarecells Diagnostics had a recent Job posting/layoffs
Product Launch: Get notified when Rarecells Diagnostics launches new products
Congratulate Masked Content for being promoted to Masked Content at Rarecells Diagnostics
Rarecells Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Rarecells Diagnostics is spiking on competitors!
Funding: Get notified immidiatlly once Rarecells Diagnostics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Rarecells Diagnostics
Compare insights from companies similar to Rarecells Diagnostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Rarecells Diagnostics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Rarecells Diagnostics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Rarecells Diagnostics.
Rarecells Diagnostics Tech Stack
A closer look at the technologies used by Rarecells Diagnostics
See more technologies
Rarecells Diagnostics News & Media
Rarecells Announces New Clinical Data Showing Superior Sensitivity and Tumor Heterogeneity Detection by Synergistic Combination of ctDNA and ISET® CTC-DNA in Patients with Early-Stage Lung Cancer
Rarecells, Inc. presented new clinical data showing superior sensitivity and tumor heterogeneity detection by ctDNA and ISET® CTC-DNA analysis.Rarecells, Inc. Appoints Dr. Rita Shaknovich to Scientific Advisory Board
Rarecells, a leader in liquid biopsy technology, appoints Dr. Rita Shaknovich to its Scientific Advisory Board.Rarecells Inc. Appoints Dr. Neil Kurtz to Board of Directors
NEW YORK and PARIS, March 26, 2025 /PRNewswire/ -- Rarecells Inc., a pioneering company in liquid biopsy technology, is pleased to announce the appointment of Dr. Neil Kurtz to its Board of Directors. Dr. Kurtz, a renowned healthcare entrepreneur and executive, brings over 40 years of...Rarecells, Inc. announces a breakthrough publication on Circulating Giant Cancer Cells detected in patients with MDS
NEW YORK and PARIS, July 20, 2023 /PRNewswire/ -- Rarecells is thrilled to announce its breakthrough publication, written in partnership with the team of Dr. Azra Raza from Columbia University Irving Medical Center, revealing for the first time the presence of circulating giant cancer...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Rarecells Diagnostics
Sign Up For FreeTo access detailed company insights
Rarecells, Inc. is a healthcare company focused on the development and commercialization of non-invasive Early Cancer Detection tests. These tests are based on the ISET® platform technology that is able to extract from blood cancer cells from any type of cancer. Cancer cells extracted by ISET® are then diagnostically identified through immune-morph... Read More
